Cargando…
From a Parkinson's disease expert: Rasagiline and the Future of Therapy
John Finberg is a professor of pharmacology at the Faculty of Medicine, Technion – Israel Institute of Technology, home of Israel's two Nobel laureates. He and his colleague Prof. Moussa Youdim were instrumental in the early clinical development of the anti-Parkinson drug rasagiline, which gain...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929084/ https://www.ncbi.nlm.nih.gov/pubmed/17617893 http://dx.doi.org/10.1186/1750-1326-2-13 |